Dio Corp

Dio Corp's capital structure is characterized by a debt-to-equity ratio of 0.42, indicating a relatively conservative leverage position. The company's liquidity is assessed as medium, with a current ratio of 1.43, suggesting it can cover its short-term obligations but with limited excess. Free cash flow is modest at 1.38 billion KRW, and operating cash flow is 16.59 billion KRW, which is positive but not robust relative to the company's revenue of 164.08 billion KRW. Profitability metrics show a mixed picture. The company's return on equity is negative at -0.71%, and return on assets is also negative at -0.42%, indicating poor capital efficiency and asset utilization. Gross profit is 110.23 billion KRW, but net income is negative at -1.36 billion KRW, reflecting operational inefficiencies or high costs. These figures fall below the industry's preferred metrics for profitability and returns, suggesting underperformance relative to peers. Dio Corp's revenue is derived from multiple segments, including dental implants, toothpaste, dental equipment, and stents. However, the input data does not provide specific revenue breakdowns by segment or geography, making it difficult to assess concentration risk. The company operates in both domestic and overseas markets, but the extent of geographic diversification is not quantified in the available data. The company's growth trajectory is uncertain. The input data does not provide forward-looking revenue guidance or historical growth rates, so it is not possible to assess whether the company is on an upward or downward trend. Analysts have provided a mean price target of 23,500 KRW, which is higher than the current market price of 16,270 KRW, suggesting some optimism about future performance. Risk factors include a negative net cash position after subtracting total debt, which could limit the company's ability to invest in growth opportunities or withstand financial shocks. The risk of dilution is assessed as low, and no specific dilution sources are identified in the input data. However, the company's negative net income and weak profitability metrics suggest potential financial instability. Recent events include analyst price targets and recommendations, with a mean recommendation of 1.50 (leaning toward buy) and a median price target of 23,500 KRW. These signals indicate some confidence in the company's future performance, but the lack of detailed earnings reports or management guidance limits the depth of insight.